Startup Deep Dive : Nutrabay — bootstrapped and profitable for 7 years before its first funding round

Three brothers ran a supplements business for seven years without taking a single rupee of institutional money, then in September 2024 they raised ₹48 crore ($5 million) anyway — not to survive, but because they had already made the business profitable without it. Nutrabay’s Series A, led by RPSG Capital Ventures with Kotak Alternate Asset Managers Limited joining in, closed only after the company had turned a ₹1.22 crore net profit on roughly ₹99 crore of FY24 revenue.

That order of events — profit first, funding second — is unusual in Indian D2C, where cash typically arrives to buy growth before the business proves it can make money on its own. Nutrabay’s pitch was built on a narrower promise: authentic sports nutrition and supplements in a category where counterfeit stock was, for years, the norm rather than the exception.

Quick facts

What they do

Nutrabay sells sports nutrition, vitamins and supplements, and health foods to Indian fitness consumers, through its own website, marketplaces, quick-commerce apps and a growing chain of physical stores. It runs two businesses under one roof: a multi-brand retail operation that stocks more than 150 third-party brands — from MuscleTech to smaller Indian labels such as Superfyou and Gladful — and its own Nutrabay-branded private label, which spans whey protein, weight gainers, fat burners, digestive fibres, peanut butter and, more recently, an Ayurvedic Shilajit line. Across both, the catalogue runs to more than 4,000 SKUs (Inc42, 2025; Snackfax-style aggregator claims of a much larger current revenue base were not corroborated and are excluded here).

The origin

The founding insight came from the supply side, not the demand side. Around 2011–12, Shreyans Jain — then working as an enterprise account executive — and his brothers Sharad and Divay noticed how unorganised India’s sports nutrition trade was: fake stock, mislabelled tins and no reliable way for a buyer to know if a protein jar was genuine (YourStory, October 2024; India Entrepreneur, 2025). Sharad had a background spanning finance and pharmaceuticals, and Divay had spent years at a pharmaceutical distribution business, Radicura Pharmaceuticals — between them, the brothers had watched the supply chain for health products from the inside (YourStory, October 2024).

They started, as most people in this business do, as distributors and resellers of imported brands. But reselling someone else’s stock meant they controlled neither authenticity nor price. That frustration is what pushed them, in 2017, to build Nutrabay as a direct platform of their own — cutting out the layers between brand and buyer, verifying every product they listed, and building supply relationships directly with manufacturers rather than through middlemen (Inc42, 2025; India Entrepreneur, 2025).

The struggle years

Nutrabay’s early years were not funded by outside capital, which meant every setback had to be absorbed out of the business’s own cash. Two are documented on the record:

• Early technology strain: the company’s site infrastructure repeatedly buckled during high-traffic sale campaigns in its first years, before it rebuilt its technology stack and fulfilment capacity to handle volume spikes (Inc42, 2025).
• A near-flat first year: Nutrabay’s first year of operation (2017) generated a small base of revenue before the business found its footing — growth only became visible once the direct-brand-partnership model and private label began to scale several years in (Inc42, 2025).

Even after the business found its feet, profitability stayed thin. As late as FY23 — six years after launch — Nutrabay recorded operating revenue of ₹89.53 crore but still posted a net loss of ₹5.8 lakh, against a ₹32.41 lakh profit the year before on a much smaller revenue base of ₹19.24 crore (Entrackr, September 2024, citing regulatory filings). Scaling fast and staying in the black, in other words, did not happen at the same time.

The turning point

The clearest inflection is FY24. Revenue rose to approximately ₹99 crore, up roughly 10.6% over FY23’s ₹89.53 crore, and — more importantly — the company turned its FY23 net loss of ₹5.8 lakh into a ₹1.22 crore net profit, with EBITDA of ₹2.26 crore (Inc42, 2025). The bigger shift was inside the mix: Nutrabay’s own private-label range, which the company had spent years building out, grew 80% year-on-year in FY24, a rate of growth its multi-brand marketplace business could not match (Inc42, 2025; Entrackr, September 2024). That was the number that mattered most to investors — a bootstrapped business that had just proven its own products, not just its distribution, could grow and turn a profit. RPSG Capital Ventures and Kotak Alternate Asset Managers wrote their first cheques into Nutrabay months after that FY24 print, in September 2024.

The money behind it

• 2017–2024: Bootstrapped. No institutional funding for roughly seven years while the business scaled to ~₹99 crore in FY24 revenue (Inc42, 2025; Entrackr, September 2024).
• September 2024 — Series A, $5 million (~₹48 crore): Led by RPSG Capital Ventures, with participation from Kotak Alternate Asset Managers Limited — Nutrabay’s first-ever institutional round (YourStory, September 2024; Entrackr, September 2024).
• What RPSG Capital Ventures brings: the venture arm of the RP-Sanjiv Goenka Group, giving Nutrabay a large, India-focused conglomerate backer rather than a pure financial investor (YourStory, September 2024).
• What Kotak Alternate Asset Managers brings: institutional-grade capital markets credibility as Nutrabay pushes toward a larger, omnichannel footprint (Entrackr, September 2024).
• Stated use of funds: omnichannel expansion — quick commerce, exclusive brand outlets — and new private-label product development (YourStory, September 2024; Entrackr, September 2024).
• Total disclosed raised: $5 million (~₹48 crore) as of September 2024; no valuation for the round has been publicly disclosed.

How it makes money

Nutrabay runs two margin structures side by side. Selling other brands’ products — the multi-brand marketplace side, with 150-plus labels and thousands of SKUs — earns it retail margin on goods it does not manufacture, which is a volume business with thinner unit economics. Its own private label, in contrast, is where it controls formulation, sourcing and packaging directly, which the company has prioritised precisely because it converts better on margin; this is the line item that grew 80% in FY24 while overall revenue grew about 10.6% (Inc42, 2025).

• Revenue in: product sales across its own D2C website (roughly half of total sales), marketplaces such as Amazon and Flipkart, quick-commerce apps including Zepto, Blinkit and Swiggy Instamart, and a small but growing base of exclusive brand outlets (Indian Retailer, 2025).
• Costs out: inventory and procurement for 4,000-plus SKUs, warehousing and fulfilment across 18,000–20,000 PIN codes, and customer acquisition — the company adds an estimated 15,000–20,000 new customers a month (Indian Retailer, 2025; Snackfax-style figures beyond this were not independently corroborated and are excluded).
• Where the margin sits: private label and direct D2C sales, where Nutrabay controls the full chain from manufacturing to delivery, rather than in resale of third-party brands (Inc42, 2025).
• The part people get wrong: Nutrabay is often read as “just another supplements website,” but its own account of the business is that the marketplace side exists to build trust and traffic, while the private label — not the third-party catalogue — is the profit engine the company has spent years engineering (Inc42, 2025).
• Take rate / fee: not published — Nutrabay does not operate a third-party marketplace commission model; it buys and resells inventory directly rather than charging listing or platform fees.

The numbers

Figures below are standalone, unit ₹ crore, drawn from regulatory-filing reporting (Entrackr, September 2024) and company-reported FY24 results (Inc42, 2025).

• FY22 to FY23: revenue grew roughly 4.7x, from ₹19.24 crore to ₹89.53 crore (Entrackr, September 2024, citing regulatory filings).
• FY23 to FY24: revenue growth slowed sharply to about 10.6%, even as the company swung from a loss to a profit (Inc42, 2025; Entrackr, September 2024).
• FY25 filings (for the entity Nutrabay Retail Private Limited) place revenue in the ₹100–150 crore band, per company-registry aggregator Tofler; the exact figure is not publicly available (Tofler, accessed September 2026).

Where the money comes from

• Channel split: the company’s own D2C website contributes close to half of total sales, with the balance spread across marketplaces, quick commerce and a nascent retail footprint (Indian Retailer, 2025).
• Product-line split: private label (Nutrabay-branded) versus multi-brand resale of 150-plus third-party labels — the former grew 80% in FY24, far outpacing the latter (Inc42, 2025).
• Geography: roughly 35% of the customer base sits in Delhi NCR, which is why the company’s first exclusive brand outlets opened there, in Uttam Nagar, before expanding further (Inc42, 2025).
• Reach: fulfilment across 18,000–20,000 PIN codes nationally, well beyond the metro base that generates most of its EBO footfall (Indian Retailer, 2025).
• The surprise: a company built to fight counterfeit imported supplements now earns its fastest growth from its own India-made private label, not from the imported multi-brand catalogue that first brought customers to the site (Inc42, 2025).

The risks

• Quick-commerce dependency in a loss-making channel: Nutrabay now sells through Zepto, Blinkit and Swiggy Instamart, but the platforms themselves are burning cash at scale — Zepto’s FY25 net loss widened to roughly ₹3,367 crore even as revenue crossed ₹9,668 crore, and Swiggy Instamart’s adjusted EBITDA loss widened to ₹840 crore in Q4 FY25 (company disclosures, cited in press reporting, 2025–2026). Brands selling through these apps are exposed to discounting and fee structures set by platforms that are themselves under margin pressure.
• Competitive intensity from a well-funded rival: HealthKart’s MuscleBlaze, alongside international entrants such as Optimum Nutrition and MyProtein, compete directly for the same sports-nutrition shopper, in a market Nutrabay itself names as crowded (search-result aggregation of competitor listings, 2025).
• The trust problem it was built to solve is still an industry-wide risk: counterfeit and mislabelled supplements remain a documented problem in the Indian market — the exact issue that founded the company in the first place — which means any lapse in Nutrabay’s own authenticity controls (tamper-evident seals, scratch-code verification) carries outsized reputational risk (Inc42, 2025; Franchise India reporting on anti-counterfeit measures).

The takeaway

Nutrabay’s lesson is not about funding timing, though the sequence — profit before capital — is unusual enough to notice. It is about what actually compounds in a resale-heavy category. The brothers spent years distributing other companies’ products before realising that the multi-brand catalogue would only ever earn them thin, competed-away margins. The thing that changed their growth curve was building something they owned outright: a private label they controlled from formulation to fulfilment. In categories crowded with resellers, owning the product — not just the storefront — is usually where the real economics start.

Frequently asked questions

What does Nutrabay sell?

Sports nutrition, vitamins and supplements, and health foods — through its own Nutrabay-branded private label and a marketplace of more than 150 third-party brands, sold via its website, quick commerce, online marketplaces and a small chain of exclusive brand outlets.

Who founded Nutrabay and when?

Brothers Shreyans Jain, Sharad Jain and Divay Prakash Jain founded Nutrabay in 2017 (some accounts date incorporation to 2016), after several years distributing imported sports-nutrition brands in India.

How much funding has Nutrabay raised?

Nutrabay was bootstrapped for roughly seven years before raising a $5 million (~₹48 crore) Series A round in September 2024, led by RPSG Capital Ventures with Kotak Alternate Asset Managers Limited also participating. No valuation for the round has been publicly disclosed.

Is Nutrabay profitable?

Yes, as of FY24: the company reported a net profit of ₹1.22 crore and EBITDA of ₹2.26 crore on revenue of approximately ₹99 crore, a turnaround from a ₹5.8 lakh net loss in FY23.

Is Nutrabay listed on the stock exchange?

No. Nutrabay is a private company with no stock exchange listing or announced IPO plans as of September 2026.

Sources

Figures are as of September 2026. Currency converted at $1 ≈ ₹96.0 as of 18 September 2026 (Trading Economics).

• Inc42 — “How Nutrabay Became An INR 100 Cr Profitable Brand With Its Lean & Frugal Playbook” (2025)
• Entrackr — “D2C retail brand Nutrabay raises $5 Mn in Series A” (September 2024)
• YourStory — “Nutrabay bags $5M in Series A round led by RPSG Capital Ventures” (September 2024)
• YourStory — “How three entrepreneurs started a sports nutrition startup to combat counterfeit products” (October 2024)
• India Entrepreneur — “The Wellness Crusader” (2025)
• Indian Retailer — “Rs 99 Crore and Counting: How Nutrabay is Fueling India’s Nutrition Boom” (2025)
• IndiaRetailing.com — “D2C nutrition brand Nutrabay targets Rs 500 crore revenue in 5 years, eyes offline expansion” (March 2025)
• Tofler — Nutrabay Retail Private Limited, company financial filing summary (accessed September 2026)
• Franchise India — “How Nutrabay Keeps One At Bay From Duplicate Health Supplements” (reporting on anti-counterfeit measures)

Found an error? Write to us and we’ll correct it in the open, dated, on the piece.